These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 334065

  • 1. Comparative study of trichothecin, amphotericin B, and 5-fluorocytosine against Cryptococcus neoformans in vitro and in vivo.
    Sneller MR, Hariri A, Sorenson WG, Larsh HW.
    Antimicrob Agents Chemother; 1977 Sep; 12(3):390-4. PubMed ID: 334065
    [Abstract] [Full Text] [Related]

  • 2. Combined activity of amphotericin B and 5-fluorocytosine against Cryptococcus neoformans in vitro and in vivo in mice.
    Hamilton JD, Elliott DM.
    J Infect Dis; 1975 Feb; 131(2):129-37. PubMed ID: 1090685
    [Abstract] [Full Text] [Related]

  • 3. Letter: Amphotericin B and 5-fluorocytosine.
    Medoff G, Kobayashi GS.
    J Infect Dis; 1975 Oct; 132(4):489-90. PubMed ID: 1102615
    [No Abstract] [Full Text] [Related]

  • 4. Combined in vitro activity of amphotericin B and 5-fluorocytosine against Cryptococcus neoformans and Candida albicans.
    Chen HH, Liushih RN, Hsieh WC.
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1982 May; 15(2):106-12. PubMed ID: 7047097
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of amphotericin B in combination with flucytosine against flucytosine-susceptible or flucytosine-resistant isolates of Cryptococcus neoformans during disseminated murine cryptococcosis.
    Schwarz P, Dromer F, Lortholary O, Dannaoui E.
    Antimicrob Agents Chemother; 2006 Jan; 50(1):113-20. PubMed ID: 16377675
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Treatment of experimental cryptococcal meningitis with amphotericin B, 5-fluorocytosine, and ketoconazole.
    Perfect JR, Durack DT.
    J Infect Dis; 1982 Sep; 146(3):429-35. PubMed ID: 6286799
    [Abstract] [Full Text] [Related]

  • 9. [Antimycotic activity in vitro and in vivo of 5-fluorocytosine on pathogenic strains of Candida albicans and Cryptococcus neoformans].
    Costa AL, Valenti A, Costa G, Calogero F.
    G Batteriol Virol Immunol; 1976 Sep; 69(7-12):244-9. PubMed ID: 800772
    [Abstract] [Full Text] [Related]

  • 10. In vitro studies with combinations of 5-fluorocytosine and amphotericin B.
    Shadomy S, Wagner G, Espinel-Ingroff E, Davis BA.
    Antimicrob Agents Chemother; 1975 Aug; 8(2):117-21. PubMed ID: 1101814
    [Abstract] [Full Text] [Related]

  • 11. Assay for yeast susceptibility to 5-fluorocytosine and amphotericin B in a frozen microtiter system.
    Ellis NS, Bartlett MS, Smith JW.
    Am J Clin Pathol; 1979 Aug; 72(2):194-8. PubMed ID: 382827
    [Abstract] [Full Text] [Related]

  • 12. Susceptibility of coccidioides immitis, Candida albicans, and Cryptococcus neoformans to amphotericin B, flucytosine, and clotrimazole.
    Hoeprich PD, Huston AC.
    J Infect Dis; 1975 Aug; 132(2):133-41. PubMed ID: 1099147
    [Abstract] [Full Text] [Related]

  • 13. Combination of oral flucytosine and ketoconazole as therapy for experimental cryptococcal meningitis.
    Craven PC, Graybill JR.
    J Infect Dis; 1984 Apr; 149(4):584-90. PubMed ID: 6327836
    [Abstract] [Full Text] [Related]

  • 14. Interactions of posaconazole and flucytosine against Cryptococcus neoformans.
    Barchiesi F, Schimizzi AM, Najvar LK, Bocanegra R, Caselli F, Di Cesare S, Giannini D, Di Francesco LF, Giacometti A, Carle F, Scalise G, Graybill JR.
    Antimicrob Agents Chemother; 2001 May; 45(5):1355-9. PubMed ID: 11302795
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. In vitro and in vivo studies on synergistic antifungal activity.
    Shadomy S.
    Contrib Microbiol Immunol; 1977 May; 4():147-57. PubMed ID: 342191
    [No Abstract] [Full Text] [Related]

  • 17. Synergistic effect of the verapamil and amphotericin B against Cryptococcus neoformans.
    Pereira TC, do Carmo PHF, de Menezes RT, de Oliveira HC, de Oliveira LD, Junqueira JC, Scorzoni L.
    Folia Microbiol (Praha); 2023 Dec; 68(6):999-1004. PubMed ID: 37950840
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of Oral Encochleated Amphotericin B in a Mouse Model of Cryptococcal Meningoencephalitis.
    Lu R, Hollingsworth C, Qiu J, Wang A, Hughes E, Xin X, Konrath KM, Elsegeiny W, Park YD, Atakulu L, Craft JC, Tramont EC, Mannino R, Williamson PR.
    mBio; 2019 May 28; 10(3):. PubMed ID: 31138748
    [Abstract] [Full Text] [Related]

  • 19. Antifungal drug combinations for Cryptococcus neoformans and Prototheca spp.
    Srimuang S, Prariyachatigul C, Chaiprasert A, Rungsipanuratn W, Tanphaichitra D.
    J Med Assoc Thai; 2000 Jan 28; 83(1):57-60. PubMed ID: 10710870
    [Abstract] [Full Text] [Related]

  • 20. Combination therapy of experimental histoplasmosis and cryptococcosis with amphotericin B and ketoconazole.
    Graybill JR, Williams DM, Van Cutsem E, Drutz DJ.
    Rev Infect Dis; 1980 Jan 28; 2(4):551-58. PubMed ID: 6255531
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.